First Citizens Bank & Trust CO Corcept Therapeutics Inc Transaction History

First Citizens Bank & Trust CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 15, 2021	SELL	$19.68 - $22.53 $186,861 - $213,922	-9,495 Closed	0 $0
Q2 2021 Jul 14, 2021	BUY	$19.97 - $24.43 $13,679 - $16,734	685 Added 7.78%	9,495 $209,000
Q1 2021 Apr 14, 2021	BUY	$23.49 - $30.56 $206,946 - $269,233	8,810 New	8,810 $210,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on First Citizens Bank & Trust CO with notifications on news.